Delivery Order SPE2DB20D1100-SPE2DB23FD3X6

Award Date 8/31/23
Potential Completion Date 9/1/23
Potential Value $146
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $448,560 delivery order to Amerisourcebergen Drug Corporation for Ipratropium Bromide 0.03% inhalation solution. The firm fixed price order is for 30mL bottles of the medication to support DLA's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. No set aside provisions or subcontractors were identified. The order was awarded utilizing an existing DLA-wide medical...
The Defense Logistics Agency awarded a $200,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ipratropium 0.03% spray. The single day contract has a period of performance from July 24, 2023 through July 25, 2023 for delivery to a location in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for a respiratory medication supports the Agency's mission to provide critical logistics capabilities...
The Defense Logistics Agency awarded a $72,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561655985, described as Ipratropium 0.03% Spray bottles of 30mL each. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from July 31, 2023 through August 1, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages...
The Defense Logistics Agency awarded a $100,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561391568 IPRATROPIUM 0.03% SPRAY 30ML. The place of performance is Conshohocken, Pennsylvania. The delivery order was awarded under an unspecified multiple award contract vehicle and has a period of performance from June 30, 2023 through July 3, 2023. As the DLA supports the procurement of medical supplies and pharmaceuticals for the U.S. military and other government...
The Defense Logistics Agency awarded a $425,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ipratropium 0.03% spray. The delivery order was issued against an undisclosed governmentwide acquisition contract vehicle or indefinite delivery/indefinite quantity contract held by Amerisourcebergen. Performance will take place in Conshohocken, Pennsylvania from August 21-22, 2023 to deliver the requested pharmaceutical product in support of Defense Logistics Agency...
The Defense Logistics Agency awarded a $201,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ipratropium Bromide 0.06% spray. As part of DLA's medical supply chain support to the Department of Defense, the delivery order is for 15ml bottles of the medication to be shipped from Amerisourcebergen's facility in Conshohocken, Pennsylvania and delivered by August 16, 2023. No major subcontractors or set aside designations were identified. The award was issued utilizing...
The Defense Logistics Agency awarded a $422,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ipratropium Bromide 0.03% spray. The single award was issued under an unspecified government-wide acquisition contract vehicle to supply 30mL bottles of the pharmaceutical to a facility in Conshohocken, Pennsylvania. Performance will be completed by July 26, 2023. As a major provider of medical supplies and logistics support to the Department of Defense, this order for a...
Defense Logistics Agency awarded Amerisourcebergen Drug Corp a $140 firm fixed price delivery order for Ipratropium 0.03% spray (30ml). The contract has no set-aside designation and requires delivery by October 6, 2023. Performance will occur in Conshohocken, Pennsylvania. As the prime contractor, Amerisourcebergen Drug Corp will provide the requested pharmaceutical products from its Corporate Office location. The Defense Logistics Agency supports America's armed forces by procuring nearly every...
The Defense Logistics Agency awarded a $47,680 delivery order to Amerisourcebergen Drug Corporation for Ipratropium Bromide 0.02% solution. The firm fixed price order is to supply 2.5mL bottles of the pharmaceutical solution from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order was awarded under an existing DLA contract vehicle and runs from September 22, 2023 through September 25, 2023 to support the Agency's medical supply needs. No set aside provisions or subcontractors...
The Defense Logistics Agency Troop Support Medical awarded a $476.52 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 4561358521 IPRATROPIUM 0.03% SPRAY 30ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from June 27, 2023 through June 28, 2023. No major subcontractors or set aside designations were indicated. This delivery order appears...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD3X6
    Delivery Order

The Defense Logistics Agency awarded a $145,680 delivery order to Amerisourcebergen Drug Corporation for 4562017506 Ipratropium 0.03% spray bottles. The firm fixed price order is for 30mL bottles of the medication to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 31st to September 1st, 2023. No subcontractors or set aside designations were identified. The order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill short-term needs for the inhalant, which is commonly used to treat respiratory conditions.

Generated 12/15/23, 1:05 AM